From: Effect of COVID-19 lockdown on Moroccan patients with type 1 and type 2 diabetes
Variables | N (%) |
---|---|
Gender | |
Male | 52 (34.7%) |
Female | 98 (65.3%) |
Place of residence | |
Urban | 135 (90%) |
Rural | 15 (10%) |
Educational level | |
Illiterate | 63 (42%) |
Primary/Koranic | 25 (16.7%) |
Middle School/High School | 24 (16%) |
University | 38 (25.3%) |
Marital status | |
Single | 31 (20.7%) |
Married | 95 (63.3%) |
Divorced | 5 (3.3%) |
Widower | 19 (12.7%) |
Professional activity | |
No occupation | 69 (46%) |
Student | 9 (6%) |
Employee | 40 (26.7%) |
Self-employed | 9 (6%) |
Retirement | 23 (15.3%) |
Insurance coverage | |
No insurance | 34 (22.7%) |
Medical insurance | 116 (77.3%) |
Socioeconomic level (income (Dhs)/year) | |
< 36,000 | 85 (56.7%) |
36,000–72,000 | 45 (30%) |
> 72,000 | 20 (13.3%) |
Type of diabetes | |
Insulin dependent (T1D) | 70 (46.7%) |
Not insulin dependent (T2D) | 80 (53.3%) |
Treatment | |
Oral antidiabetic agents (T2D) | 80 (53.3%) |
Insulin (T1D) | 51 (72.85%) |
Oral antidiabetic agents per day + Insulin (T1D) | 19 (27.15%) |
Type of insulin (effect) | |
Slow/semi-slow | 42 (28%) |
Fast | 8 (5.3%) |
Both | 20 (13.3%) |
Insulin doses per day | |
Once/day | 10 (6.7%) |
2 times/day | 48 (32%) |
3 times/day | 12 (8%) |
Oral antidiabetic agents doses per day | |
Once/day | 26 (17.3%) |
2 times/day | 37 (24.7%) |
3 times/day | 36 (24%) |
Comorbidities | |
Yes | 81 (54%) |
No | 69 (46%) |
Type of comorbidity | |
None | 69 (46%) |
Hypertension | 48 (32%) |
Renal failure | 3 (2%) |
Obesity/overweight | 11 (7.3%) |
Others | 18 (12%) |
Complications | |
Yes | 69 (46%) |
No | 81 (54%) |
Housing | |
Alone | 10 (6.7%) |
With family | 140 (93.3%) |
Adherence to dietary guidelines (pre-lockdown) | |
Yes | 113 (75.3%) |
No | 37 (24.7%) |
Adherence to dietary guidelines (post-lockdown) | |
Yes | 106 (70.7%) |
No | 44 (29.3%) |
Physical activity (≥ three times 30 min per week) | |
Yes | 92 (61.3%) |
No | 58 (38.7%) |
Type of physical activity | |
Walking | 54.70% |
Soccer | 2.70% |
Other (aerobics, cycling, taekwondo, running, etc.) | 42.60% |
Respect of appointments (pre-lockdown) | |
Yes | 116 (77.3%) |
No | 34 (22.7%) |
Respect of appointments (during lockdown) | |
Yes | 87 (58%) |
No | 63 (42%) |
Stopping medication (pre-lockdown) | |
Yes | 22 (14.7%) |
No | 128 (85.3%) |
Stopping medication (during lockdown) | |
Yes | 31 (20.7%) |
No | 118 (78.7%) |
Self-monitoring (pre-lockdown) | |
Rarely or never | 49 (32.7%) |
If symptom | 29 (19.3%) |
2 times/week | 11 (7.4%) |
Once/day | 61 (40.7%) |
Self-monitoring (during lockdown) | |
Rarely or never | 55 (36.7%) |
If symptom | 23 (15.3%) |
2 times/week | 14 (9.3%) |
Once/day | 58 (38.7%) |
Fasting (during lockdown) | |
Yes | 96 (64%) |
No | 54 (36%) |
Anxiety about getting COVID-19 (during lockdown) | |
Yes | 91 (60.7%) |
No | 59 (39.3%) |
COVID-19 infection | |
Yes | 15 (10%) |
No | 135 (90%) |
COVID-19 vaccination | |
Yes | 90 (60%) |
No | 60 (40%) |
Doses of COVID-19 vaccination | |
1 dose | 17 (18.9%) |
2 doses | 73 (81.1%) |